Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase NA 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 10Other 2Lymphoid 2Classical hematology 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Hematologic Neoplasms 272Leukemia, Myeloid, Acute 255Leukemia 234Lymphoma 127Leukemia, Lymphocytic, Chronic, B-Cell 110Multiple Myeloma 108Neoplasms 95Myelodysplastic Syndromes 95Lymphoma, Non-Hodgkin 94Hodgkin Disease 76Burkitt Lymphoma 64Lymphoma, Mantle-Cell 61Lymphoma, Follicular 60Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Lymphoma, Large B-Cell, Diffuse 56Myeloproliferative Disorders 54Lymphoma, B-Cell, Marginal Zone 53Lymphoma, Large-Cell, Immunoblastic 47Congenital Abnormalities 47Motor Activity 45Leukemia, Myeloid, Chronic-Phase 45Primary Myelofibrosis 43Lymphoma, T-Cell, Cutaneous 43Recurrence 41Sezary Syndrome 39Mycosis Fungoides 39Leukemia, Myeloid, Accelerated Phase 38Neoplasms, Plasma Cell 35Breast Neoplasms 35

Interventions

Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Renal Insufficiency × Other hematologic neoplasm × Clear all
NCT02360111 2019-07-24

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Memorial Sloan Kettering Cancer Center

Phase NA Terminated
3 enrolled 6 charts
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡